RO6874281 is a bispecific IL2 immunocytokine which targets cancer associated fibroblasts via binding to FAP and has shown potent anti-tumor activity in melanoma, neuroblastoma and colon carcinoma models [141]. This evidence concerns the gene FAP and neuroblastoma.